FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

G W D Weijers

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Procedures

Physiology

Cell Movement

Concepts & Ideas

Co-author Network

Publications

TOP 3
Nicole Feller; Marjolein A van der Pol; Taco Waaijman; G W D Weijers; Guus Westra; Gert Ossenkoppele; Gerrit J Schuurhuis
Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients.
Nicole Feller; Marjolein A van der Pol; Amber van Stijn; G W D Weijers; August H Westra; B W Evertse; Gert Ossenkoppele; Gerrit J Schuurhuis
MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia.
Marjolein A van der Pol; Nicole Feller; Gert Ossenkoppele; G W D Weijers; August H Westra; Amber van Stijn; Henk J Broxterman; Gerrit J Schuurhuis
Minimal residual disease in acute myeloid leukemia is predicted by P-glycoprotein activity but not by multidrug resistance protein activity at diagnosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of G W D Weijers (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Nicole Feller; Marjolein A van der Pol; Taco Waaijman; G W D Weijers; Guus Westra; Gert Ossenkoppele; Gerrit J Schuurhuis
Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13):4793-801.
2004: Nicole Feller; Marjolein A van der Pol; Amber van Stijn; G W D Weijers; August H Westra; B W Evertse; Gert Ossenkoppele; Gerrit J Schuurhuis
MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia.
Leukemia 2004;18(8):1380-90.
2003: Marjolein A van der Pol; Nicole Feller; Gert Ossenkoppele; G W D Weijers; August H Westra; Amber van Stijn; Henk J Broxterman; Gerrit J Schuurhuis
Minimal residual disease in acute myeloid leukemia is predicted by P-glycoprotein activity but not by multidrug resistance protein activity at diagnosis.
Leukemia 2003;17(8):1674-7.
2003: Marjolein A van der Pol; Henk J Broxterman; Jennie M Pater; Nicole Feller; Martin van der Maas; G W D Weijers; George L Scheffer; John D Allen; Rik J Scheper; Arnold van Loevezijn; Gert Ossenkoppele; Gerrit J Schuurhuis
Function of the ABC transporters, P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemia.
Haematologica 2003;88(2):134-47.
2003: Nicole Feller; Gerrit J Schuurhuis; Marjolein A van der Pol; Guus Westra; G W D Weijers; Amber van Stijn; Peter C Huijgens; Gert Ossenkoppele
High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome.
Leukemia 2003;17(1):68-75.
2002: Fransien de Boer; Angelika M Dräger; HERBERT PINEDO; Floortje L Kessler; M Monnee-van Muijen; G W D Weijers; Guus Westra; ELSKEN VAN DER WALL; Tanja Netelenbos; Jan W Oberink; Peter C Huijgens; Gerrit J Schuurhuis
Early apoptosis largely accounts for functional impairment of CD34+ cells in frozen-thawed stem cell grafts.
Journal of hematotherapy & stem cell research 2002;11(6):951-63.